|
Fighting bacteria with a new genre of antibodies
Eureka! Science News Their inspiration was the antibodies that the immune system produces when microbes invade the body. Those antibodies patrol the body for microbes and bind to their surfaces, triggering a chain of events in which the body’s immune system attacks and … |
US Heart Failure Costs Could Skyrocket: Report – U.S. News & World Report
|
US Heart Failure Costs Could Skyrocket: Report
U.S. News & World Report That means that by 2030, every U.S. taxpayer could be paying $244 a year to care for heart failure patients, according to the American Heart Association policy statement. It said the findings highlight the need for strategies to prevent and treat heart … Costs to treat heart failure expected to more than double by 2030 – Medical XpressMedical Xpress Durham University researchers find one in five care home patients may have …The Northern Echo ALMH Offers New Heart Failure Disease Management ProgramLincoln Courier |
Brain-dead organ donor dashed across Atlantic to save others – Digital Journal – DigitalJournal.com
 DigitalJournal.com |
Brain-dead organ donor dashed across Atlantic to save others – Digital Journal
DigitalJournal.com Sima, a former nurse, and organ donor card carrier, had been in New Jersey for a week when she had a seizure said to have been caused by a previously undetected congenital defect in her blood vessels. She was declared brain-dead in New Jersey and … Trans-Atlantic dash fulfills organ donor’s wishesThe Times of Israel |
XDx Announces Presentations at Upcoming 2013 International Society for Heart … – Fort Mills Times
|
XDx Announces Presentations at Upcoming 2013 International Society for Heart …
Fort Mills Times These findings were presented in a late breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT)’s 32nd Annual Meeting & Scientific Sessions, held in April 2012, in Prague, Czech Republic. The oral presentation … |
XDx Announces Presentations at Upcoming 2013 International Society for Heart … – Business Wire (press release)
|
XDx Announces Presentations at Upcoming 2013 International Society for Heart …
Business Wire (press release) These findings were presented in a late breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT)’s 32nd Annual Meeting & Scientific Sessions, held in April 2012, in Prague, Czech Republic. The oral presentation … |
Majority of children readmitted to hospital following stem cell transplant – Science Daily (press release)
|
Majority of children readmitted to hospital following stem cell transplant
Science Daily (press release) Apr. 24, 2013 — Nearly two-thirds of children receiving stem cell transplants returned to the hospital within six months for treatment of unexplained fevers, infections or other problems, according to a study performed at Dana-Farber/Children’s … |
Fighting bacteria with a new genre of antibodies – EurekAlert! – EurekAlert (press release)
Fighting bacteria with a new genre of antibodies – EurekAlert!EurekAlert (press release)In an advance toward coping with bacteria that shrug off existing antibiotics and sterilization methods, scientists are reporting development of a new family of sel…
Face transplant success paves way for feet – Adelaide Now
|
Face transplant success paves way for feet
Adelaide Now Surgeons are also making progress in transplant surgery for people who have lost a limb, he said. “Again that’s an experimental protocol. But people have reattached (a patient’s) own limb if it’s amputated. Hands were more commonly reattached than … Boston ‘best place to help bomb victims’ – NinemsnNinemsn |
Video reveals cancer cells' Achilles' heel – EurekAlert! – EurekAlert (press release)
|
Video reveals cancer cells’ Achilles’ heel – EurekAlert!
EurekAlert (press release) Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B cells. It is widely used in the treatment of B cell malignancies, such as lymphoma and leukaemia – as well … |
Pre-clinical results on naproxcinod in models of muscular dystrophy – Pharmacy Europe
Pre-clinical results on naproxcinod in models of muscular dystrophyPharmacy EuropeThree doses of naproxcinod (10, 21 and 41mg/kg) were given orally to four-week-old mdx mice (a reference model for Duchenne Muscular Dystrophy, DMD) for nine months and c…